Norges Bank Ideaya Biosciences, Inc. Transaction History

Norges Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $3.18 Million - $4.02 Million	92,600 New	92,600 $3.25 Million
Q3 2023 Nov 13, 2024	BUY	$21.07 - $29.77 $269,696 - $381,056	12,800 New	12,800 $345,000
Q2 2023 Aug 14, 2024	BUY	$13.33 - $25.53 $330,584 - $633,144	24,800 Added 26.78%	117,400 $2.76 Million
Q1 2023 May 15, 2024	BUY	$13.49 - $18.72 $1.58 Million - $2.2 Million	117,400 New	117,400 $1.61 Million
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $1.99 Million - $2.5 Million	137,500 New	137,500 $2.5 Million
Q3 2019 Nov 08, 2019	SELL	$6.06 - $10.91 $60,599 - $109,100	-10,000 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$9.58 - $11.95 $95,800 - $119,500	10,000 New	10,000 $100,000

216

80.8M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.33B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.